News | Concert AI

The Role of Technology in CAPAs | ConcertAI

Written by ConcertAI | Apr 14, 2022 4:00:00 AM

12-Apr-2022 by Susan Haigney

Pharmaceutical Technology asked Jeff Elton, PhD, CEO of ConcertAI, about the role technology plays in performing CAPAs.

Performing corrective action and preventive action (CAPA) activities is often necessary to investigate a manufacturing deviation and prevent it from reoccurring. Pharmaceutical Technology asked Jeff Elton, PhD, CEO of ConcertAI, about the role technology plays in performing CAPAs.

PharmTech:How can technology be used to prepare and perform CAPAs? In investigating deficiencies, and/or developing action plans?

Elton (ConcertAI): Technology and AI [artificial intelligence] can, and should, be used to create and maintain effective CAPA plans, in clinical trials, real-world evidence (RWE), and medical devices ecosystem. In FDA’s three draft guidance documents published at the close of 2021 on the use of RWE, a number of key technical characteristics were noted as foundation. Upon integration of those across all technical environments interacting with study data, technologies can allow a study dataset to be considered a ‘package’ of data that includes details on its source, source relevance, reliability, etc. These same technologies also allow surveillance of data for anomalies and errors can assemble data to a specified cohort and create registries and comparative data sets assuring consistency with the study plan and any preliminary analyses…

 

Read More